Devon Duron Ehnes

Dr. Devon Duron Ehnes

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
YZYan Ting Zhao
Yan Ting Zhao
JFJorge A. Fallas
Jorge A. Fallas
SSShally Saini
Shally Saini
GUGeorge Ueda
George Ueda
LSLogeshwaran Somasundaram
Logeshwaran Somasundaram
Hannele Ruohola-BakerHannele Ruohola-Baker
Hannele Ruohola-Baker
Angiopoietin 1 and 2 (Ang1 and Ang2) modulate angiogenesis and vascular homeostasis through engagement of their very similar F-domain modules with the Tie2 receptor tyrosine kinase on endothelial cells. Despite this similarity in the underlying receptor binding interaction, the two angiopoietins have opposite effects: Ang1 induces phosphorylation of protein kinase B (AKT), strengthens cell-cell junctions and enhances endothelial cell survival while Ang2 antagonizes these effects 1–4 . To investigate the molecular basis for the opposing effects, we examined the protein kinase activation and morphological phenotypes produced by a series of computationally designed protein scaffolds presenting the Ang1 F-domain in a wide range of valencies and geometries. We find two broad phenotypic classes distinguished by the number of presented F-domains: scaffolds presenting 4 F-domains have Ang2 like activity, upregulating pFAK and pERK but not pAKT, and failing to induce cell migration and tube formation, while scaffolds presenting 6 or more F-domains have Ang1 like activity, upregulating pAKT and inducing migration and tube formation. The scaffolds with 8 or more F-domains display superagonist activity, producing stronger phenotypes at lower concentrations than Ang1. When examined in vivo , superagonist icosahedral self-assembling nanoparticles caused significant revascularization in hemorrhagic brains after a controlled cortical impact injury.

10 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AAA Alghadeer
A Alghadeer
SHS Hanson-Drury
S Hanson-Drury
DEDevon Duron Ehnes
Devon Duron Ehnes
YZYt Zhao
Yt Zhao
APAP Patni
AP Patni
Hannele Ruohola-BakerHannele Ruohola-Baker
Hannele Ruohola-Baker
Tooth enamel secreted by ameloblasts is the hardest material in the human body, acting as a shield protecting the teeth. However, the enamel is gradually damaged or partially lost in over 90% of adults and cannot be regenerated due to a lack of ameloblasts in erupted teeth. Here we use sci-RNA-seq to establish a spatiotemporal single-cell atlas for the developing human tooth and identify regulatory mechanisms controlling the differentiation process of human ameloblasts. We reveal key signaling pathways involved between the support cells and ameloblasts during fetal development and recapitulate those findings in a novel human ameloblast in vitro differentiation from iPSCs. We furthermore develop a mineralizing enamel organ-like 3D organoid system. These studies pave the way for future regenerative dentistry and therapies toward genetic diseases affecting enamel formation.

30 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
YZYan Ting Zhao
Yan Ting Zhao
DEDevon Duron Ehnes
Devon Duron Ehnes
Julie MathieuJulie Mathieu
Julie Mathieu
Hannele Ruohola-BakerHannele Ruohola-Baker
Hannele Ruohola-Baker
The Angiopoietin–Tie2 pathway is a key regulator of postnatal vascular maintenance and remodeling, regulating vascular barrier function and integrity. While the opposing roles of the ligands Angiopoietin-1 (Ang 1) and Angiopoietin-2 (Ang 2) have been recognized for decades, the structural mechanism governing their distinct signaling outputs has only recently been elucidated. As artificial intelligence and protein design continue to develop, emerging evidence suggests that ligand valency and receptor clustering are key determinants of Tie2 pathway activation and endothelial cell function; that is, “form follows function”. This review summarizes the latest discovery in the structural biology and signaling mechanism of the Tie2 pathway using protein design to decode the ligand–receptor interactions. Probing the underlying molecular basis of Tie2 offers new therapeutic opportunities for targeting diseases, featuring vascular dysfunctions such as sepsis, traumatic brain injury, acute respiratory diseases, chronic inflammation, and cancer. This also highlights the next generation of AI-designed protein therapeutics.

3 October 2025 in bioRxiv
Verified
Preprint
Open access
DEDevon Duron Ehnes
Devon Duron Ehnes
AMAkira Morishita
Akira Morishita
APAshish Phal
Ashish Phal
HJHee Yun Jung
Hee Yun Jung
YLYen Chian Lim
Yen Chian Lim
Hannele Ruohola-BakerHannele Ruohola-Baker
Hannele Ruohola-Baker
Summary: Salivary glands are highly susceptible to injury and degeneration. To facilitate studies in human salivary gland disease, we developed a rapid protocol for 3D hiPSC-derived salivary gland organoids that recapitulate human fetal salivary gland gene expression and function, have both ductal and acinar cell types, secretory capacity, and the ability to respond to cholinergic agonism. Oral health issues resulting from diabetes mellitus have been attributed to salivary gland dysfunction, leading to chronic xerostomia and increased dental caries. To study diabetic salivary gland hypofunction, we further developed a diabetic model, demonstrating diabetic hallmarks including FOXO1 nuclear localization, AGE-RAGE signaling, and defective oxidative phosphorylation, which were by treatment with the diabetic drug Metformin. Our model has implications for the development of effective therapeutics against salivary gland dysfunction in diabetes and other metabolic diseases in exocrine tissues.